These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 22160274)

  • 41. Atrial resynchronization therapy in patients with atrial fibrillation and heart failure with and without systolic left ventricular dysfunction: a pilot study.
    Saksena S; Slee A; Saad M
    J Interv Card Electrophysiol; 2018 Oct; 53(1):9-17. PubMed ID: 29987682
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Complications and 1-year benefit of cardiac resynchronization therapy in patients over 75 years of age - Insights from the German Device Registry.
    Köbe J; Andresen D; Maier S; Stellbrink C; Kleemann T; Gonska BD; Reif S; Hochadel M; Senges J; Eckardt L
    Int J Cardiol; 2017 Feb; 228():784-789. PubMed ID: 27898337
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Benefit of cardiac resynchronization therapy in atrial fibrillation patients vs. patients in sinus rhythm: the role of atrioventricular junction ablation.
    Ferreira AM; Adragão P; Cavaco DM; Candeias R; Morgado FB; Santos KR; Santos E; Silva JA
    Europace; 2008 Jul; 10(7):809-15. PubMed ID: 18511438
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Atrial fibrillation burden and subsequent heart failure events in patients with cardiac resynchronization therapy devices.
    Tanawuttiwat T; Lande J; Smeets P; Gerritse B; Nazarian S; Guallar E; Cheng A
    J Cardiovasc Electrophysiol; 2020 Jun; 31(6):1519-1526. PubMed ID: 32162753
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Atrial fibrillation in cardiac resynchronization recipients with and without prior arrhythmic history. How much of arrhythmia is too much?
    Lenarczyk R; Jędrzejczyk-Patej E; Szulik M; Mazurek M; Podolecki T; Kowalczyk J; Kowalski O; Średniawa B; Kalarus Z;
    Cardiol J; 2015; 22(3):267-75. PubMed ID: 25563708
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Atrioventricular nodal ablation in patients with resynchronization therapy and atrial fibrillation - long term results.
    Aune A; Færestrand S; Hoff PI; Schuster P
    Scand Cardiovasc J; 2017 Jun; 51(3):138-142. PubMed ID: 28345365
    [TBL] [Abstract][Full Text] [Related]  

  • 47. AV junction ablation and cardiac resynchronization for patients with permanent atrial fibrillation and narrow QRS: the APAF-CRT mortality trial.
    Brignole M; Pentimalli F; Palmisano P; Landolina M; Quartieri F; Occhetta E; Calò L; Mascia G; Mont L; Vernooy K; van Dijk V; Allaart C; Fauchier L; Gasparini M; Parati G; Soranna D; Rienstra M; Van Gelder IC;
    Eur Heart J; 2021 Dec; 42(46):4731-4739. PubMed ID: 34453840
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Treatment of atrial fibrillation with a dual defibrillator in heart failure patients (TRADE HF): protocol for a randomized clinical trial.
    Botto GL; Boriani G; Favale S; Landolina M; Molon G; Tondo C; Biffi M; Grandinetti G; De Filippo P; Raciti G; Padeletti L
    Trials; 2011 Feb; 12():44. PubMed ID: 21324118
    [TBL] [Abstract][Full Text] [Related]  

  • 49. CHADS2 and CHA2DS2-VASc scores to predict morbidity and mortality in heart failure patients candidates to cardiac resynchronization therapy.
    Paoletti Perini A; Bartolini S; Pieragnoli P; Ricciardi G; Perrotta L; Valleggi A; Vergaro G; Michelotti F; Boggian G; Sassone B; Mascioli G; Emdin M; Padeletti L
    Europace; 2014 Jan; 16(1):71-80. PubMed ID: 23828875
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Comparative Effectiveness of Cardiac Resynchronization Therapy Among Patients With Heart Failure and Atrial Fibrillation: Findings From the National Cardiovascular Data Registry's Implantable Cardioverter-Defibrillator Registry.
    Khazanie P; Greiner MA; Al-Khatib SM; Piccini JP; Turakhia MP; Varosy PD; Masoudi FA; Curtis LH; Hernandez AF;
    Circ Heart Fail; 2016 Jun; 9(6):. PubMed ID: 27296396
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Cardiac resynchronisation therapy in chronic atrial fibrillation: impact on left atrial size and reversal to sinus rhythm.
    Kiès P; Leclercq C; Bleeker GB; Crocq C; Molhoek SG; Poulain C; van Erven L; Bootsma M; Zeppenfeld K; van der Wall EE; Daubert JC; Schalij MJ; Bax JJ
    Heart; 2006 Apr; 92(4):490-4. PubMed ID: 16159986
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Efficacy, safety, and outcomes of catheter ablation of atrial fibrillation in patients with heart failure with preserved ejection fraction.
    Machino-Ohtsuka T; Seo Y; Ishizu T; Sugano A; Atsumi A; Yamamoto M; Kawamura R; Machino T; Kuroki K; Yamasaki H; Igarashi M; Sekiguchi Y; Aonuma K
    J Am Coll Cardiol; 2013 Nov; 62(20):1857-65. PubMed ID: 23916940
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Comparison of benefits and mortality in cardiac resynchronization therapy in patients with atrial fibrillation versus patients in sinus rhythm (Results of the Spanish Atrial Fibrillation and Resynchronization [SPARE] Study).
    Tolosana JM; Hernandez Madrid A; Brugada J; Sitges M; Garcia Bolao I; Fernandez Lozano I; Martinez Ferrer J; Quesada A; Macias A; Marin W; Escudier JM; Gomez AA; Gimenez Alcala M; Tamborero D; Berruezo A; Mont L;
    Am J Cardiol; 2008 Aug; 102(4):444-9. PubMed ID: 18678303
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Detection of atrial high-rate events by continuous home monitoring: clinical significance in the heart failure-cardiac resynchronization therapy population.
    Shanmugam N; Boerdlein A; Proff J; Ong P; Valencia O; Maier SK; Bauer WR; Paul V; Sack S
    Europace; 2012 Feb; 14(2):230-7. PubMed ID: 21933802
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Probability of sinus rhythm conversion and maintenance in cardiac resynchronization therapy patients with atrial fibrillation during 5-year follow-up.
    Ziegelhoeffer T; Pecha S; Rahmani R; Thaqi N; Ackermann X; Hakmi S; Choi YH; Burger H
    J Cardiovasc Electrophysiol; 2020 Sep; 31(9):2393-2402. PubMed ID: 32652754
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Comparison of response to cardiac resynchronization therapy in patients with sinus rhythm versus chronic atrial fibrillation.
    Molhoek SG; Bax JJ; Bleeker GB; Boersma E; van Erven L; Steendijk P; van der Wall EE; Schalij MJ
    Am J Cardiol; 2004 Dec; 94(12):1506-9. PubMed ID: 15589005
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Cardiac resynchronization therapy improves ejection fraction and cardiac remodelling regardless of patients' age.
    Brambatti M; Guerra F; Matassini MV; Cipolletta L; Barbarossa A; Urbinati A; Marchesini M; Capucci A
    Europace; 2013 May; 15(5):704-10. PubMed ID: 23385052
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Atrial high-rate episodes predict clinical outcome in patients with cardiac resynchronization therapy.
    Jacobsson J; Platonov PG; Reitan C; Carlsson J; Borgquist R
    Scand Cardiovasc J; 2017 Apr; 51(2):74-81. PubMed ID: 27841021
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Development of Heart Failure From Transient Atrial Fibrillation Attacks in Responders to Cardiac Resynchronization Therapy.
    Nakajima I; Noda T; Kanzaski H; Kamakura T; Wada M; Ishibashi K; Inoue Y; Miyamoto K; Okamura H; Nagase S; Aiba T; Kamakura S; Noguchi T; Yasuda S; Akashi YJ; Kusano KF
    JACC Clin Electrophysiol; 2018 Sep; 4(9):1227-1234. PubMed ID: 30236398
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Four-year efficacy of cardiac resynchronization therapy on exercise tolerance and disease progression: the importance of performing atrioventricular junction ablation in patients with atrial fibrillation.
    Gasparini M; Auricchio A; Regoli F; Fantoni C; Kawabata M; Galimberti P; Pini D; Ceriotti C; Gronda E; Klersy C; Fratini S; Klein HH
    J Am Coll Cardiol; 2006 Aug; 48(4):734-43. PubMed ID: 16904542
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.